Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Cocrystals: Industry Takes a Wait-and-See Approach

The perceived risks associated with cocrystals may be slowing progress of their industrial application.
May 30, 2014

The perceived risks associated with cocrystals may be slowing progress of their industrial application.

HPAPIs: Fast-growing Segment Presents Challenges and Opportunities

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.
May 30, 2014

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

Drug developers are taking a wait-and-see approach to the use of cocrystals.
May 2, 2014

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Process Design Is Critical for Commercial Manufacture of HPAPIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
May 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Packaging Becomes Enabler for Biopharmaceuticals

May 2, 2014

Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.

Advances in Continuous Biopharmaceutical Manufacturing

Both upstream and downstream processes can benefit from continuous manufacturing advantages.
Apr 16, 2014

Both upstream and downstream processes can benefit from continuous manufacturing advantages.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Apr 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
Apr 2, 2014

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.
Apr 1, 2014

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here